Why sleep can feel different

Taking longer to fall asleep, waking during the night, or waking earlier than planned can become more noticeable during perimenopause. In a longitudinal analysis of more than 3,000 participants in the Study of Women’s Health Across the Nation, self-reported insomnia symptoms appeared in 31% to 42% of perimenopausal participants at a given annual study interval. Symptoms were more common in later than earlier perimenopause. These group findings describe a pattern; they cannot explain any one person’s sleep.

Night sweats and hot flashes can interrupt sleep, but menopause is only one possible contributor. Stress, mood changes, pain, caregiving, shift work, medication effects, alcohol, sleep apnea, and restless legs can also play a part. Some people have persistent sleep difficulty without noticeable hot flashes. A useful assessment considers the whole picture rather than assuming that every sleepless night is hormonal.

Progesterone, brain signalling and sleep

As ovulation becomes less predictable during perimenopause, some cycles may not have the usual post-ovulation rise in progesterone. Hormone patterns vary from cycle to cycle. This helps explain why progesterone may be part of the sleep conversation, while leaving room to consider other contributors to disrupted sleep.4

One reason progesterone may affect sleep is that the body converts it to allopregnanolone, a neuroactive steroid that influences GABA-A receptors involved in inhibitory brain signalling. This may contribute to the sleepiness some people experience with oral micronized progesterone.5 Brain circuits that generate sleep spindles also involve GABA signalling, although the receptor systems and experimental findings are complex.14 These links offer a possible mechanism; clinical treatment studies are needed to establish what they mean for sleep quality in perimenopause.

What progesterone treatment studies tell us

In a Canadian placebo-controlled trial, 189 perimenopausal women with hot flashes or night sweats were assigned 300 mg oral micronized progesterone at bedtime or placebo for 12 weeks. The primary hot-flash/night-sweat score did not differ significantly between groups, although the study could not rule out a clinically meaningful benefit. At the end, participants taking progesterone more often reported improved sleep quality and fewer night sweats.13 Sleep quality was self-reported; the study did not record EEG or test whether spindles changed.

A systematic review of micronized-progesterone trials found a pooled improvement in time to fall asleep, but not a clear improvement in total sleep time or sleep efficiency. Most participants were postmenopausal, and some studies combined progesterone with estrogen or could not separate sleep effects from fewer vasomotor symptoms.7 These results support a potential sleep benefit, with uncertainty about who is most likely to respond and which sleep measures improve. They do not establish a spindle-restoration mechanism.

The Menopause Society’s 2022 statement also recognizes sleep benefits with oral micronized progesterone in some settings. It describes progesterone-alone use for sleep or vasomotor symptoms as off-label and notes the lack of long-term data.15

A useful follow-up considers how you actually sleep, daytime function, side effects and whether other sleep conditions need attention. A meaningful individual improvement can coexist with unanswered research questions about how that improvement occurs.

What sleep-spindle research can tell us

Sleep spindles are brief bursts of brain-wave activity during non-REM sleep. Researchers measure them with an overnight EEG; they are one feature of sleep microarchitecture, not a direct score of how rested someone feels.

In a sleep-laboratory study of 20 women in the early menopause transition who still had ovulatory cycles, spindle density and length were greater in the progesterone-rising luteal phase. Yet that phase also involved more awakenings and arousals and a lower percentage of deep (N3) sleep. The study compared one night in each cycle phase; it did not give progesterone as treatment. Its results show why more spindles cannot automatically be interpreted as better sleep.12

A separate small observational study compared 21 women taking depot medroxyprogesterone acetate (MPA), a synthetic progestin, with matched women referred for sleep testing. The MPA group had greater spindle density and maximum amplitude.8 This was not a trial, did not test oral micronized progesterone, and did not establish that the spindle difference caused better perceived sleep. It cannot establish whether oral micronized progesterone restores spindles or whether spindles account for an improvement in sleep.

Notice patterns without turning sleep into another job

For one or two weeks, jot down a few details: when you went to bed, roughly how long it took to fall asleep, when you woke, whether you noticed heat or sweating, and how rested you felt the next day. Add relevant notes about cycle changes, medication or supplement changes, alcohol or caffeine timing, stress, and daytime sleepiness. A simple note is enough; a perfect sleep diary is not required.

Patterns can help you and your clinician decide what questions to explore. For example, repeated waking with a racing mind may call for a different conversation than waking hot several times a night or feeling unrefreshed despite enough hours in bed. Bring the notes to your appointment if they are useful, and stop tracking if it increases worry.

Gentle steps that may support rest

  • Keep a reasonably regular wake time when your schedule allows.
  • Make the bedroom comfortable for you, including temperature, light, and noise.
  • Notice whether late-day caffeine or alcohol seems to affect your sleep; responses vary.
  • Build a brief wind-down routine that feels realistic rather than adding a demanding checklist.
  • If worry about sleep is growing, ask about evidence-based support such as cognitive behavioural therapy for insomnia (CBT-I).

These are general ideas, not a treatment plan. A clinician can help assess persistent symptoms and discuss options that fit your health history and preferences.

Magnesium: what the evidence can tell us

Magnesium is an essential mineral that has been studied for insomnia, but evidence for a sleep benefit remains limited. A small placebo-controlled trial in older adults reported improvements in some insomnia measures.9 A systematic review found three small randomized trials involving 151 older adults. Pooled results suggested magnesium shortened the time it took to fall asleep by about 17 minutes; total sleep time did not improve significantly, and the evidence was rated low to very low quality. These findings do not establish that magnesium improves perimenopausal sleep specifically.10

Magnesium is found in foods such as legumes, nuts, seeds, whole grains and leafy green vegetables. If you are considering a supplement, discuss the product and dose with a health-care professional, particularly if you have kidney disease or take regular medication. Supplemental magnesium can cause diarrhoea and can interfere with absorption of some antibiotics and osteoporosis medicines; impaired kidney function can increase the risk of magnesium building up in the body.11

When to seek an assessment

Consider making an appointment if sleep problems continue, affect work or daily life, or leave you feeling persistently exhausted. Mention loud snoring, gasping, morning headaches, uncomfortable urges to move your legs, significant mood changes, or medication concerns. Those clues can point to issues that deserve their own assessment. If sleepiness makes driving or another activity unsafe, do not wait for a routine check-in to address safety.

A useful starting point

You do not need to arrive with a diagnosis or a perfect explanation. A clear description of what changed, how long it has been happening, and what matters most to you is a strong place to begin. Sleep can improve when the factors affecting it are identified and addressed one at a time.

Sources and further reading

  1. Longitudinal Study of Insomnia Symptoms Among Women During Perimenopause Ciano C, King TS, Wright RR, Perlis M, Sawyer AM. Journal of Obstetric, Gynecologic & Neonatal Nursing. 2017.
  2. Sleep problems during the menopausal transition: prevalence, impact, and management challenges Baker FC, de Zambotti M, Colrain IM, Bei B. Nature and Science of Sleep. 2018.
  3. Sleep Trajectories Before and After the Final Menstrual Period in SWAN Kravitz HM, et al. Menopause. 2017.
  4. Progesterone and ovulation across stages of the transition to menopause Longitudinal study of ovulation and progesterone patterns across the menopause transition. Menopause. 2009.
  5. Allopregnanolone: state of the art Melcangi RC, Panzica G. Progress in Neurobiology. 2014. Review of allopregnanolone and GABA-A receptor signalling.
  6. Sleep in menopause: differential effects of two forms of hormone replacement therapy Montplaisir J, Lorrain J, Denesle R, Petit D. Randomized sleep-laboratory study in 21 postmenopausal women receiving estrogen with either medroxyprogesterone acetate or micronized progesterone. Menopause. 2001;8(1):10–16.
  7. Efficacy of Micronized Progesterone for Sleep: A Systematic Review and Meta-analysis of Randomized Controlled Trial Data Nolan BJ, Liang B, Cheung AS. Journal of Clinical Endocrinology & Metabolism. 2021;106(4):e942–e951.
  8. Medroxyprogesterone acetate is associated with increased sleep spindles during non-rapid eye movement sleep in women referred for polysomnography Plante DT, Goldstein MR. Observational comparison involving depot medroxyprogesterone acetate, a synthetic progestin. Psychoneuroendocrinology. 2013.
  9. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial Abbasi B, et al. Small randomized placebo-controlled trial in older adults. Journal of Research in Medical Sciences. 2012.
  10. Oral magnesium supplementation for insomnia in older adults: a systematic review and meta-analysis Mah J, Pitre T. Three randomized trials; 151 older adults. BMC Complementary Medicine and Therapies. 2021.
  11. Magnesium: Fact Sheet for Health Professionals U.S. National Institutes of Health, Office of Dietary Supplements. Supplement safety, medication interactions and kidney function.
  12. Menstrual Cycle-Related Variation in Physiological Sleep in Women in the Early Menopausal Transition Sassoon SA, de Zambotti M, Colrain IM, Baker FC. Sleep. 2015;38(4):591–599. Sleep-laboratory comparison of follicular and luteal phases in 20 women in the early menopause transition.
  13. Oral micronized progesterone for perimenopausal night sweats and hot flushes: a Phase III Canada-wide randomized placebo-controlled trial Prior JC, Cameron A, Fung M, et al. Scientific Reports. 2023;13:9082. Perimenopausal vasomotor-symptom trial; sleep quality was self-reported, not measured by EEG.
  14. GABA-B receptor subtypes differentially regulate thalamic spindle oscillations Ulrich D, Lalanne T, Gassmann M, Bettler B. Neuropharmacology. 2018;136(Pt A):106–116. Experimental mechanistic research using mouse thalamic preparations; it does not test progesterone treatment or clinical sleep outcomes.
  15. The 2022 hormone therapy position statement of The North American Menopause Society The North American Menopause Society Advisory Panel. Menopause. 2022;29(7):767–794. Includes discussion of oral micronized progesterone, sleep and the evidence limits.

This article is general education, not medical advice, diagnosis, or an individual care plan. Discuss personal health questions with a qualified health-care professional.